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Introduction
Reactive oxygen species (ROS) are generated dur-
ing normal cellular metabolism, as a result of the 
influence of various environmental factors, as well as
during pathological processes [1]. ROS are responsible
for DNA, lipid and protein damage and play an impor-
tant role in the development and progression of many
human diseases, including cancer [2]. Protein oxida-
tion may result in structural changes and loss of func-
tion through peptide bond cleavage due to oxidation
of the protein backbone, formation of protein–protein
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Abstract
To study the role of oxidative stress in breast cancer risk, we analysed plasma levels of protein carbonyls in
1050 cases and 1107 controls. We found a statistically significant trend in breast cancer risk in relation to
increasing quartiles of plasma protein carbonyl levels (OR=1.2, 95% CI=0.9–1.5; OR=1.5, 95% CI=1.2–2.0;
OR=1.6, 95% CI=1.2–2.1, for the 2nd, 3rd and 4th quartile relative to the lowest quartile, respectively, P for
trend=0.0001). The increase in risk was similar for younger (<50 years) and older women, more pronounced
among women with higher physical activity levels (≥0.7 hrs/week for 4th quartile versus lowest quartile
OR=2.0, 95% CI=1.4–3.0), higher alcohol consumption (≥15 grams/day for 4th quartile versus lowest quartile
OR=2.3, 95% CI=1.1–4.7), and hormone replacement therapy use (HRT, OR=2.6, 95% CI=1.6–4.4 for 4th
quartile versus lowest quartile). The multiplicative interaction terms were statistically significant only for phys-
ical activity and HRT. The positive association between plasma protein carbonyl levels and breast cancer risk
was also observed when the analysis was restricted to women who had not received chemotherapy or radi-
ation therapy prior to blood collection. Among controls, oxidized protein levels significantly increased with cig-
arette smoking and higher fruit and vegetable consumption, and decreased with alcohol consumption >30
grams per day. Women with higher levels of plasma protein carbonyl and urinary 15F2t-isoprostane had an
80% increase in breast cancer risk (OR=1.8, 95% CI=1.2–2.6) compared to women with levels below the
median for both markers of oxidative stress. In summary, our results suggest that increased plasma protein
carbonyl levels may be associated with breast cancer risk.
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cross-linked derivatives or oxidation of amino acid
side chains [3]. The oxidation of protein side chains
occurs mainly on proline, arginine, lysine and threo-
nine residues resulting in carbonyl formation [4].
Carbonyl groups formed during the oxidation are
chemically stable which is useful for both in terms of
detection and stability during sample storage [4].
Protein carbonyl levels are the most frequently
used biomarker of protein oxidation and their accu-
mulation has been observed with aging and in sever-
al human diseases, including cancer (reviewed in
[5];[6]). Several methods of protein carbonyl groups
detection are available [5], including a colorimetric
assay based on derivatization of the carbonyl group
with 2,4-dinitrophenylhydrazine (DNPH) [7]. A stable
2,4-nitrophenylhydrazone (DNP) product results that
can be detected spectrophotometrically. Because
this method is relatively time-consuming and
requires higher amount of biological samples, Buss
et al. [8] developed a highly sensitive enzyme-linked
immunosorbent assay using anti-DNP antibodies.
The assay is reproducible and correlates well with
the classical colorimetric assay.
In the present study, we investigated the associa-
tion of oxidative stress, measured as the levels of
protein carbonyl groups in plasma, with breast can-
cer risk among women who participated in the Long
Island Breast Cancer Study Project (LIBCSP).
Among controls, we also determined the correlation
of plasma protein carbonyl levels with age, average
lifetime physical activity, fruit and vegetable intake,
alcohol consumption, cigarette smoking, body mass




The LIBCSP is a population-based study investigating the
associations between environmental factors and breast
cancer. Details of the case-control study design were
described previously [9]. Briefly, eligible cases were women
residing in Nassau or Suffolk counties, who spoke English,
and were newly diagnosed with a first primary in situ or
invasive breast cancer between August 1, 1996, and July
31, 1997. There were no age or race restrictions.
Population-based controls were identified using random
digit dialling (<65 years of age) and Health Care Financing
Administration rosters (65+ years of age), and frequency
matched to the expected age distribution of the cases by 
5-year age group.
Covariate exposure assessment
The main questionnaire was administered by a trained
interviewer in the participant's home and lasted approxi-
mately 2 hrs. Information was assessed on known and sus-
pected risk factors for breast cancer, including passive and
active cigarette smoking, lifetime alcohol use, menstrual
and reproductive histories, hormone use, body size by
decade of adult life, lifetime participation in recreational
activities, prior medical history and family history of 
breast cancer (http://epi.grants.cancer.gov/LIBCSP/proj-
ects/ Questionnaire.html). Usual dietary intake in the year
prior to the interview was assessed using a modified Block
self-administered food frequency questionnaire, as previ-
ously described [10]. We also collected information on can-
cer treatment undergone prior to blood collection, including
whether a participant had radiation and/or chemotherapy.
Of the eligible participants who completed the main
questionnaire (1508 cases and 1556 controls), 73% of
cases and 73% of controls donated a non-fasting blood
samples at the time of the interview. The samples were
donated on average within 3 months after breast cancer
diagnosis, prior to the onset of chemotherapy for most case
participants, but after surgery. For controls, the time lag
between the identification and the interview was about 5.5
months. Blood samples, collected in ethylenediaminete-
traacetic acid (EDTA)-treated tubes, were shipped at room
temperature for overnight delivery to Columbia University
for processing and storage. The samples were aliquoted
and frozen at 80C within 24 hrs of collection. In the pres-
ent study, blood plasma samples from 1050 cases and
1107 controls were analysed.
Plasma protein carbonyl assay
The levels of plasma protein carbonyl groups were
assessed using a non-competitive ELISA, essentially as
described in [8], with some modifications [11]. Briefly, the
oxidized protein standards were prepared by incubation of
bovine serum albumin (BSA) (50 mg/ml) with 0.73 M H2O2
and 0.42 mM Fe2+ for 1 hr at 37C. The reaction was
stopped with 40 µM butylated hydroxytoluene.The carbonyl
content of the oxidized BSA standard was measured spec-
trophotometrically [7]. It was then diluted with native (unox-
idized) BSA and phosphate-buffered saline (PBS) to give a
final carbonyl content of 2.0 nmol/mg protein and protein
concentration of 4 mg/ml. Total protein concentration in the
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plasma samples was measured using Bicinchoninic Acid
Kit (Sigma) and the samples were diluted with PBS to a
final protein concentration of 4 mg/ml. After the derivatiza-
tion with DNPH, the plate was coated with 200 µl of sam-
ple (1 µg) and incubated overnight at 4C in the dark. The
plate was washed with PBS/Tween (0.05% Tween 20 in
PBS) and blocked with 0.1% BSA in PBS for 1.5 hr. After
another washing step, biotinylated primary anti-DNP anti-
body (Molecular Probes; diluted 1:1500 with 0.1% BSA,
0.1% Tween 20 in PBS) was added and the plate was incu-
bated at 37C for 1 hr. Another washing was followed by
adding the streptavidin-biotynylated horseradish peroxi-
dase conjugate (Amersham; diluted 1:4000 in 0.1% BSA,
0.1% Tween 20 in PBS) and incubation at room tempera-
ture for 1 hr. Colour was developed by adding the tetram-
ethyl benzidine (TMB) liquid substrate system (Sigma) and
the reaction was stopped with H2SO4 after 15–25 min incu-
bation in the dark. The absorbance was measured with a
microplate reader at 450 nm. Plasma protein carbonyl con-
centration was expressed as nmol carbonyl/ml plasma.
Each sample was analysed in duplicate; the interassay
coefficient of variability for the repeat analysis (N=53) of a
quality control sample was 17%. As a quality control, a
pooled plasma sample was repeatedly frozen and thawed
before analysis; there was no significant difference in pro-
tein carbonyl levels with up to four freeze-thaw cycles.
Statistical analysis
The SAS statistical software (Version 9) was used to
analyse these data. We first compared the differences
between 1050 cases and 1107 controls with regard to the
plasma protein carbonyl levels (nmol carbonyl/ml plasma).
The Analysis of Variance Test [12] was used for comparing
case-control differences as continuous variables and the
chi-square Test [13] was used for comparing case-control
differences. Quantiles of plasma protein carbonyl levels
were created based on the distribution among controls. We
also examined case-control differences using uncondition-
al logistic regression [14] adjusting for reference age (date
of diagnosis for cases and date of identification for con-
trols). Other factors that were considered as possible con-
founders include those that have been associated with
breast cancer and may also influence oxidative stress path-
ways, including average physical activity level, fruit and
vegetable intake, average lifetime alcohol intake, active cig-
arette smoking status, BMI, menopausal status, age at
menarche, age at first birth (AFB), parity, oral contraceptive
(OC) use and hormone replacement therapy (HRT) use
(using definitions that have been previously published
[10,15–17]). Only those that changed the effect estimates
by more than 10% were included in the final models. We
stratified the association between plasma protein carbonyl
levels and breast cancer by the same factors to examine
effect modification on a multiplicative scale. We also exam-
ined the associations with the cases restricted to those
women for whom chemotherapy (N=827) or radiation ther-
apy (N=831) had not yet been initiated by the time of the
blood collection.
We then assessed whether plasma protein carbonyl lev-
els differed by age, average physical activity level, fruit and
vegetable intake, average lifetime alcohol intake, active
smoking status, BMI, menopausal status, age at menar-
che, AFB, parity, OC use and HRT use among 1107 con-
trols first by using the Analysis of Variance Test and second
by using linear regression methods [13]. We used log trans-
formation for the plasma protein carbonyl levels in the lin-
ear regression model to meet the assumption of normality.
We estimated a saturated model with all factors suspected
to influence plasma protein carbonyl levels and a parsimo-
nious model with other those variables which were statisti-
cally significantly related to the outcome.
Results
We observed a statistically significant trend in breast
cancer risk in relation to increasing quartiles of plasma
protein carbonyl levels (multivariate-adjusted OR =
1.2, 95% CI = 0.9–1.5; OR = 1.5, 95% CI = 1.2–2.0;
OR = 1.6, 95% CI = 1.2-2.1 for the 2nd, 3rd and 4th
quartile relative to the lowest quartile, respectively, P
for trend = 0.0001) (Table 1). Estimates differed little
between models with and without adjustment for other
breast cancer risk factors. Among cases, there were
no differences in plasma protein carbonyl level
between those with or without chemotherapy or radiation
therapy prior to blood collection. Considering plasma
protein carbonyl levels categorized into other quartile
groupings (tertiles, quintiles, deciles) yielded similar
effect estimates (data not shown). Thus, after removal
of the 214 women who had received chemotherapy
and the 209 who had received radiation therapy,
results did not materially change (OR = 1.1, 95% CI =
0.8–1.5; OR = 1.7, 95% CI =1.2–2.3; OR = 1.7, 95%
CI 1.2–2.3 for the 2nd, 3rd and 4th quartile relative to
the lowest quartile, respectively, P for trend = 0.0001).
We also determined whether removal of women 
currently on HRT impacted results but again they did
not materially change (OR = 1.0, 95% CI =0.7–1.4;
OR = 1.4, 95% CI =1.0–2.0; OR = 1.3, 95% CI 0.9–1.8
for the 2nd, 3rd and 4th quartile relative to the lowest
quartile, P for trend = 0.02). Removing those who
J. Cell. Mol. Med. Vol 11, No 5, 2007
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received chemotherapy and radiation therapy in addi-
tion to those on HRT resulted in ORs of 1.0 (95% CI
0.7–1.4), 1.6 (95%CI 1.1–2.3 and 1.4 (95%CI 0.9–2.0)
for the 2nd, 3rd and 4th quartile relative to the lowest
quartile (P for trend = 0.02).
The increase in breast cancer risk by quartile of
plasma protein carbonyl level was similar for younger
(<50 years) and older women or by fruits and vegeta-
bles consumption (Table 2). The association between
plasma protein carbonyl level and breast cancer risk
was more pronounced among women with higher
physical activity levels ( 0.7 hrs/week for 4th quartile
versus lowest quartile OR = 2.0, 95% CI = 1.4–3.0),
with higher average lifetime alcohol consumption 
( 15 grams/day for 4th quartile versus lowest quar-
tile OR = 2.3, 95% CI = 1.1–4.9) and who used HRT
(OR = 2.6, 95%CI = 1.6–4.4 for 4th quartile versus
lowest quartile). But, the multiplicative interaction
terms were statistically significant only for physical
activity (P=0.02) and use of HRT (P =0.04).
To assess whether breast cancer risk is related to
increased levels of markers of protein oxidation and
lipid peroxidation, we compared plasma protein car-
bonyl levels and urinary 15F2t-isoprostane levels
(analysed in a subset of 400 cases and 401 controls
in our previous study [18]). Women with higher levels
of plasma protein carbonyl (≥ median) and higher
levels of 15F2t-isoprostane (≥ median) had a 1.8-fold
increase in breast cancer risk (OR = 1.8, 95% CI =
1.2–2.6) compared to women with levels below the
median for both markers of oxidative stress (Table 3).
In univariate analyses, among controls, plasma
protein carbonyl levels significantly increased with
age (P=0.02, Table 4), and were significantly higher
in post-menopausal compared to pre-menopausal
women (P=0.01) and in those with age of menarche
<13 yrs (P<0.01). Contrary to our expectations, lev-
els were also higher with increased fruits and vegeta-
bles intake (P=0.04). Similar trends were observed
when fruits and vegetables were considered sepa-
rately. No significant associations were found
between plasma protein carbonyl levels and average
physical activity level, average lifetime alcohol 
intake, cigarette smoking status, BMI and other
reproductive variables.
Table 5 reports the findings from multivariate linear
regression models examining the association between
selected breast cancer risk factors and plasma protein
carbonyl levels among controls. Higher average physi-
cal activity, higher consumption of alcohol and later age
of menarche were associated with decreased plasma
protein carbonyl levels. In the best-fitting model, higher
fruit and vegetable intake and post-menopausal status
were associated with increased plasma protein car-
bonyl levels and high alcohol consumption and later
age of menarche with decreased levels.
Discussion
Protein oxidation, measured as plasma levels of pro-
tein carbonyl groups, was significantly associated
with breast cancer risk in our study. Participants with
the highest quartile of plasma protein carbonyl levels
had a 60% increased risk of developing breast cancer
compared to participants with plasma protein car-
bonyl levels in the lowest quartile. Several previous
studies have provided evidence that protein oxidation
might be associated with cancer risk. Increased lev-
els of plasma protein carbonyl groups were observed
in patients with Hodgkin's lymphoma [19], with blad-
der cancer [20] and in children with various malig-
Protein carbonyl
(nmol/ml)
Cases (%) Controls (%) Odds ratio* (95% CI) Odds ratio** (95% CI)
<11.5 191 (18) 276 (25) 1.00 1.00
11.5–14.8 240 (23) 277 (25) 1.23 (0.96, 1.59) 1.18 (0.90, 1.55)
>14.8–19.2 304 (29) 276 (25) 1.58 (1.23, 2.02) 1.51 (1.16, 1.97)
>19.2 312 (30) 277 (25) 1.60 (1.25, 2.04) 1.60 (1.23, 2.09)
P<0.0001 p = 0.0001
Table 1 Adjusted odds ratios and 95% confidence intervals for breast cancer associated with plasma protein carbonyl level
* Adjusted for age.
** Adjusted for age, average physical activity level, fruits and vegetables intake, average alcohol intake, active smoking status,
menopausal status, BMI, ever use HRT, ever use OC, age at menarche, parity and age at first birth.
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OR* (95% CI)
<11.5 11.5–14.8 >14.8–19.2 >19.2
N=191/276$ N=240/277 N=304/276 N=312/277
Age (years) <50 1.00 1.22 (0.74–2.02) 1.42 (0.87–2.33) 1.76 (1.07–2.90)
≥50 1.00 1.17 (0.84–1.64) 1.56 (1.13–2.15) 1.52 (1.10–2.09)
Average physical activity
level (hrs/week)
<0.7 1.00 1.43 (0.97–2.11) 1.41 (0.97–2.05) 1.29 (0.89–1.89)
≥0.7 1.00 0.94 (0.63–1.39) 1.64 (1.11–2.43) 2.04 (1.39–2.99)
Fruits and vegetables
intake (No. of 1/2 cup
serving/week)
<27 1.00 1.17 (0.78–1.77) 1.84 (1.22–2.78) 1.73 (1.14–2.64)
≥27 1.00 1.13 (0.78–1.64) 1.29 (0.90–1.84) 1.50 (1.06–2.13)
Average lifetime alcohol
intake (gram/day)
Non-drinkers 1.00 0.98 (0.62–1.55) 1.33 (0.85–2.07) 1.32 (0.85–2.05)
<15 1.00 1.39 (0.93–2.07) 1.57 (1.06–2.32) 1.74 (1.17–2.57)
≥15 1.00 1.14 (0.54–2.40) 1.82 (0.88–3.77) 2.30 (1.09–4.85)
Cigarette smoking status Never 1.00 1.34 (0.90–2.01) 1.62 (1.09–2.39) 2.02 (1.37–2.97)
Current 1.00 1.08 (0.56–2.07) 1.27 (0.66–2.36) 1.71 (0.86–3.32)
Former 1.00 1.06 (0.65–1.72) 1.57 (0.98–2.52) 1.20 (0.75–1.91)
BMI (kg/m2) <25 1.00 1.05 (0.70–1.57) 1.47 (0.99–2.18) 1.72 (1.16–2.55)
≥25 1.00 1.37 (0.94–2.01) 1.55 (1.07–2.25) 1.60 (1.10–2.32)
Menopausal status Pre-menopausal 1.00 1.21 (0.76–1.93) 1.74 (1.09–2.75) 1.87 (1.17–3.00)
Post-menopausal 1.00 1.14 (0.81–1.61) 1.39 (0.99–1.94) 1.49 (1.07–2.07)
Ever use HRT Non-users 1.00 1.00 (0.72–1.38) 1.42 (1.03–1.96) 1.30 (0.94–1.78)
Users 1.00 1.75 (1.02–3.02) 1.56 (0.94–2.58) 2.64 (1.59–4.40)
Ever use OC Non-users 1.00 1.50 (1.01–2.21) 1.39 (0.95–2.01) 1.79 (1.23–2.60)
Users 1.00 0.93 (0.63–1.38) 1.69 (1.15–2.50) 1.43 (0.97–2.11)
Age at menarche <13 yrs 1.00 1.12 (0.76–1.65) 1.32 (0.91–1.89) 1.41 (0.98–2.04)
≥13 yrs 1.00 1.23 (0.83–1.83) 1.86 (1.24–2.78) 1.86 (1.24–2.79)
Parity Nulliparous 1.00 1.41 (0.59–3.36) 1.29 (0.54–3.07) 2.31 (1.02–5.21)
Parous 1.00 1.18 (0.88–1.58) 1.56 (1.18–2.07) 1.55 (1.17–2.06)
Age at first birth <25 yrs 1.00 1.23 (0.82–1.84) 1.67 (1.13–2.47) 1.21 (0.82–1.79)
≥25 yrs 1.00 1.15 (0.74–1.78) 1.50 (0.98–2.28) 2.12 (1.37–3.26)
Table 2 Breast cancer risk associated with plasma protein carbonyl level stratified by age, average physical activity
level, fruits and vegetable intake, alcohol intake, cigarette smoking status, BMI, menopausal status, HRT and OC use,
age of menarche and first birth and parity
*Adjusted for age, average physical activity level, fruits and vegetables intake, average alcohol intake, active smoking status,
menopausal status, BMI, ever use HRT, ever use OC, age at menarche, parity and age at first birth.
$ N=cases/controls.
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nancies [21], but not in a small study of lung cancer
[22]. To the best of our knowledge, our study is the
first analysis of the relationship between protein oxi-
dation and breast cancer risk. Also, our study com-
pletes the investigation of a panel of oxidative stress
markers among the participants of LIBCSP [18].
According to a recent report [23], it is critical to simul-
taneously analyse several markers of oxidative
stress to better understand the processes leading to
the particular pathology being studied.
The process of aging is accompanied by increasing
levels of oxidative damage, including protein oxidation
(reviewed in [3]). Increased levels of protein carbonyls
have been observed in elderly participants as com-
pared with younger participants in some [24], [25] but
not all [26] studies. We also found increased plasma
protein carbonyl levels in older women (Table 4).
In the multivariate analysis, higher physical activity
was associated with decreased plasma protein
carbonyl levels (Table 5). In general, physical exer-
cise can produce an imbalance between ROS and
antioxidants and thus lead to oxidative stress [27],
but the results of different studies are conflicting.
Decreased plasma protein carbonyl levels were
found in participants after strenuous physical exer-
cise [28] and in sedentary participants as a result of
physical exercise [29], but levels increased in partic-
ipants in a super-marathon race [30]. Thus, the bio-
logical meaning of our observation is not clear; how-
ever, it is in agreement with other studies.
Fruits and vegetables contain both antioxidant and
pro-oxidant factors so their effect on oxidative stress
markers may be variable. Decreased levels of vari-
ous oxidative stress markers have been observed
after administration of fruits and vegetables-rich food
in several studies [31–33]. Analysis of data from the
LIBCSP showed that higher fruits and vegetables
consumption was associated with significantly
decreased breast cancer risk among post-
menopausal women (OR 0.72, 95% CI 0.53–0.99 for
the highest quintile compared with the lowest) with
weaker associations among pre-menopausal [10].
Contrary to this data, we observed significantly
increased plasma protein carbonyl levels among par-
ticipants with higher fruits and vegetables consump-
tion (Table 4& 5). Similar results were observed by
Dragsted et al. [34] in an intervention study where
participants receiving a diet rich in fruits and vegeta-
bles, or a pill containing vitamins and minerals corre-
sponding to those in the fruits and vegetables diet,
had higher protein carbonyl formation at lysine
residues than those on placebo. They hypothesized
that the pro-oxidant activity of vitamin C might 
be responsible for their findings. Thus fruits and 
vegetables may protect against breast cancer by
multiple pathways.
Alcohol induces oxidative stress due to the metab-
olism of ethanol. Three pathways of ethanol metabo-
lism have been described and each results in free
radical production leading to oxidative damage [35].
Several studies have observed increased protein
carbonyl levels among patients with chronic alco-
holism [36–38] suggesting that repeated exposure to
high alcohol levels may be necessary to affect pro-
tein carbonyl levels. Lower levels of oxidative stress
markers were reported among moderate alcohol
drinkers [39, 40], but these studies concentrated on
white and red wine drinkers. It is probable that the
presence of antioxidants in wine diminishes the neg-
ative effect of ethanol on oxidative stress markers. In
the present study, we saw significantly lower plasma
protein carbonyl levels with elevated alcohol intake.
This may reflect the type of alcoholic beverages con-
sumed by the participants in our study (prevalence of
wines rich in antioxidants), as well as relatively low
levels of alcohol exposure that were not sufficient to
Table 3 Breast cancer risk associated with the 15-F2t-isoprostane and plasma protein carbonyl levels
15F2tisoprostane Carbonyl Cases (%) Controls (%) OR (95% CI)*
<median <median 73 (18) 92 (23) 1.00
median <median 80 (21) 107 (27) 0.94 (0.62, 1.44)
<median ≥median 88 (22) 98 (25) 1.07 (0.70, 1.63)
median ≥median 154 (39) 103 (26) 1.76 (1.19, 2.62)
P = 0.002
* Adjusted for age.
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Table 4 Mean (and SD) of plasma protein carbonyl levels (continuous) within strata of age, average physical activity
level, fruits and vegetables intake, average lifetime alcohol intake, cigarette smoking status, body mass index (BMI) and
menopausal status, ever use HRT, ever use OC, age at menarche, parity and age at first birth among controls
Risk factor N Carbonyl P value* Log-Carbonyl P value*
Age (years) 20–39 102 14.9±7.0 2.58±0.55
40–49 266 16.2±12.4 2.66±0.48
50–59 315 16.6±6.6 2.73±0.44
60+ 424 15.7±5.9 0.25 2.68±0.40 0.02
Average 
physical activity level (hrs/week)
0 276 16.4±6.4 2.72±0.40
<0.69 243 16.8±12.8 2.69±0.51
0.70–2.6 263 15.5±6.4 2.67±0.39
2.7+ 257 15.6±6.6 0.26 2.64±0.49 0.27
Fruits and 
vegetables intake 
(No. of # cup serving/week)
0–18 246 16.2±12.9 2.63±0.58
19–26 220 14.9±5.7 2.63±0.41
27–34 197 16.1±6.8 2.70±0.40
35–46 220 16.2±6.1 2.72±0.38
47+ 208 16.6±6.5 0.29 2.73±0.41 0.04
Average 
lifetime alcohol intake (gram/day)
Non-drinkers 403 16.1±6.2 2.70±0.42
<15 545 16.0±9.7 2.67±0.45
15–30 84 16.4±7.5 2.70±0.44
30+ 74 14.6±5.9 0.49 2.57±0.58 0.10
Cigarette 
smoking status
Never 501 15.7± 6.5 2.65±0.48
Current 208 16.6± 13.2 2.69±0.45
Former 396 16.2±6.5 0.37 2.71±0.39 0.18
BMI (kg/m2) <25 548 16.0±9.7 2.67±0.48
≥25 544 16.1±6.4 0.88 2.70±0.42 0.25
Menopausal Status Pre-menopausal 373 15.5±7.0 2.64±0.49
Post-menopausal 688 16.4±8.9 0.10 2.71±0.42 0.01
Ever use HRT Non-users 799 16.1±8.8 2.69±0.45
Users 307 15.7±6.4 0.38 2.66±0.44 0.47
Ever use OC Non-users 562 15.9±6.0 2.70±0.39
Users 544 16.1±10.0 0.68 2.66±0.50 0.24
Age at 
menarche
<13 yrs 608 16.4±6.4 2.72±0.41
≥13 yrs 491 15.6 ± 10.0 0.10 2.63±0.49 <0.01
Parity Nulliparous 123 16.2±6.4 2.70±0.40
Parous 983 16.0±8.4 0.84 2.68±0.45 0.53
Age at first birth <25 yrs 553 16.0±6.3 2.69±0.43
≥25 yrs 430 16.0±10.5 0.90 2.66±0.47 0.26
* Comparing differences between mean values by category.
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Table 5 Multivariate estimates of the association among age, average physical activity level, fruit and vegetable intake,
average lifetime alcohol intake, cigarette smoking status, body mass index (BMI), menopausal status, ever used HRT,
ever used OC, age at menarche, parity, and age at first birth and the log of plasma protein carbonyl levels among controls
Risk factor  (95% CI)*  (95% CI)**  (95% CI)***
Age (years) 20–39 Reference Reference
40–49 0.09 (-0.02, 0.19) 0.09 (-0.02, 0.20)
50–59 0.15 (0.05, 0.25) 0.07 (-0.07, 0.20)
≥60 0.11 (0.01, 0.20) 0.01 (-0.14, 0.16)
Average physical activity 
level (hrs/week)
0 Reference Reference
<0.69 -0.02 (-0.10, 0.05) -0.02 (-0.10, 0.06)
0.70–2.6 -0.04 (-0.12, 0.03) -0.06 (-0.14, 0.02)
≥2.7 -0.07 (-0.15, 0.01) -0.09 (-0.17, -0.004)
Fruits and vegetables intake 
(No. of 1/2 cup serving/week)
0–18 Reference Reference Reference
19–26 -0.003 (-0.08, 0.08) -0.01 (-0.10, 0.08) -0.01 (-0.10, 0.07)
27–34 0.07 (-0.02, 0.15) 0.07 (-0.03, 0.16) 0.06 (-0.03, 0.15)
35–46 0.08 (-0.002, 0.16) 0.11 (0.02, 0.20) 0.08 (-0.001, 0.17)
≥47 0.09 (0.01, 0.18) 0.12 (0.02, 0.21) 0.09 (0.005, 0.18)
Average lifetime alcohol intake
(gram/day)
Non-drinkers Reference Reference Reference
<15 -0.02 (-0.08, 0.03) -0.02 (-0.08, 0.04) -0.03 (-0.09, 0.03)
15–30 0.004 (-0.10, 0.11) 0.01 (-0.10, 0.13) -0.02 (-0.09, 0.13)
≥30 -0.13 (-0.24, -0.02) -0.14 (-0.27, -0.01) -0.12 (-0.24, -0.005)
Cigarette smoking status Never Reference Reference Reference
Current 0.05 (-0.03, 0.12) 0.05 (-0.03, 0.14) 0.06 (-0.02, 0.14)
Former 0.05 (-0.01, 0.11) 0.07 (0.003, 0.14) 0.05 (-0.01, 0.12)
BMI (kg/m2) <25 Reference Reference
≥25 0.03 (-0.03, 0.08) 0.01 (-0.05, 0.06)
Menopausal status Pre-menopausal Reference Reference Reference
Post-menopausal 0.10 (0.02, 0.18) 0.09 (-0.01, 0.18) 0.11 (0.02, 0.20)
Ever use HRT Non-users Reference Reference Reference
Users -0.03 (-0.09, 0.03) -0.06 (-0.12, 0.01) -0.06 (-0.12, 0.01)
Ever use OC Non-users Reference Reference
Users -0.02 (-0.08, 0.04) -0.01 (-0.07, 0.06)
Age at menarche <13 yrs Reference Reference Reference
≥13 yrs -0.09 (-0.14, -0.04) -0.08 (-0.14, -0.02) -0.08 (-0.13, -0.02)
Parity Nulliparous Reference Reference
Parous -0.04 (-0.12, 0.05) -0.05 (-0.14, 0.05)
Age at first birth <25 yrs Reference Reference
≥25 yrs -0.03 (-0.09, 0.03) -0.03 (-0.10, 0.03)
* Adjusted for age.
** Adjusted for age, average physical activity level, fruits and vegetables intake, average lifetime alcohol intake, active smoking
status, body mass index, menopausal status, ever use HRT, ever use OC, age at menarche, parity and age at first birth.
*** Best-fitting model.
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increase oxidative stress even in the group of women
consuming >30 g alcohol/day.
Significantly increased levels of oxidized proteins
in smokers than in non-smokers were observed [22]
with similar, but non-significant results in another
study [11]. We found a significant increase in plasma
protein carbonyl levels among former smokers com-
pared with non-smokers (Table 5). We observed no
modification by BMI, parity or AFB. Plasma protein
carbonyl levels were significantly lower in those with
older age at menarche. Shorter life-time exposure to
estrogen as a result of late menarche may decrease
oxidative stress induced by estrogen metabolism.
In our previous study [18], we observed an asso-
ciation between urinary 15-F2t-isoproprostane, a
marker of lipid peroxidation, and breast cancer risk in
a subset of women analysed in the present study.
The combination of elevated ( median) plasma 
protein carbonyl and 15-F2t-isoproprostane levels
resulted in a 1.8-fold increase in breast cancer risk
compared to women with levels below the median for
both markers of oxidative stress. Analysis of a com-
bination of several oxidative stress markers may pro-
vide more relevant information about risk than any
one measure.
A limitation of our study is that the blood samples
were shipped at room temperature after collection
and haemolysis may have contributed to additional
oxidative stress. However, all samples were handled
the same way and thus, time between collection of
samples and their processing cannot account for the
differences between cases and controls. Another lim-
itation is that samples were collected after breast
cancer diagnosis. Although extensive efforts were
undertaken to obtain the samples prior to the onset
of chemotherapy and radiation therapy for most case
participants, all breast cancer cases had undergone
surgery before blood draw [9]. It has been shown that
surgery results in significant decrease of ROS pro-
duction and levels of oxidative stress markers,
including protein carbonyl levels in colon [41] and
laryngeal cancer patients [42]. Moreover, total plas-
ma antioxidant capacity increases after a tumour
removal [43]. In our study, we observed no effect of
non-surgical treatment on carbonyl level and when
we restricted our analyses to case participants who
had not received chemotherapy and radiation thera-
py prior to blood collection, our results did not
change substantially. A prospective study using sam-
ples collected before diagnosis may be more useful
for determining if elevated levels of protein oxidation
predict breast cancer risk. A major strength of our
study is the large number of participants, which
helped to ensure that the study had sufficient power.
In addition, the population-based study design
ensured that cases and controls arose from the
same source population.
In summary, we found positive associations between
plasma protein carbonyl levels and breast cancer risk in
this population-based, case-control study. Among con-
trols, oxidized protein levels significantly increased with
cigarette smoking and, unexpectedly, with higher fruit
and vegetable consumption but decreased with alcohol
consumption >30 grams per day. Elevation in two oxida-
tive stress biomarkers, urinary 15F2t-isoprostanes and
oxidized protein was associated with increased breast
cancer risk. Our results add additional support to the
hypothesis that oxidative stress may play a role in
breast cancer etiology.
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